Studies patient experiences in trials for plaque psoriasis
Follows plaque psoriasis patients in a clinical study, tracking completion and withdrawal rates.
Plain-language title generated from the registry record
Registry title: Understanding Participation Habits Among Plaque Psoriasis Patients
Key facts
- Where
- San Francisco, United StatesSee the site
Where in United States
- Power Life SciencesSan Francisco, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Power Life Sciences Inc.
- Trial code
- NCT06338358
- Record updated
- 29 March 2024
- Original description
The study intends to investigate the personal experiences of plaque psoriasis patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal.Read full original descriptionShow less
In the Patient's Words: Understanding Patient Participation and Engagement in Plaque Psoriasis Clinical Trials
The study intends to investigate the personal experiences of plaque psoriasis patients who take part in a separate clinical study including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal.
The data collected from this study will help improve future outcomes for all plaque psoriasis as well as those in under-represented demographic groups.
Inclusion: Patients diagnosed with plaque psoriasis; Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed; Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion: Any serious and/or unstable pre-existing medical disorders; Refusal of consent; Women of childbearing potential without a negative pregnancy test; or women who are lactating.